Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Blood cancers, Cell type, Low grade lymphoma, Lymphoma, Non-Hodgkin lymphoma (NHL)
Closed
Phase 3
This trial is looking at a drug called ibrutinib alongside chemotherapy and rituximab for low grade lymphoma that has got worse or come back despite having other treatment.
Certain types of non Hodgkin lymphoma are slow growing. They are called low grade or indolent lymphoma.
Recruitment start: 24 March 2014
Recruitment end: 31 October 2015
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Simon Rule
Janssen-Cilag
NIHR Clinical Research Network: Cancer
Last reviewed: 12 November 2015
CRUK internal database number: 11349
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
